News
Omega-3 Fish Oil Supplements: What Clinical Trials Show About Heart and Metabolic Health
Understanding Omega-3 Fatty Acids: EPA and DHA
Omega-3 polyunsaturated fatty acids are essential nutrients that play structural and functional roles in the human body. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are two major long-chain omega-3s found in marine sources such as oily fish and microalgae. These fatty acids integrate into cell membranes, influencing membrane fluidity, cell signaling, and systemic inflammatory pathways.
Because dietary intake of omega-3s can be lower than recommended, dietary supplements and prescription formulations are frequently studied to evaluate their effects on cardiovascular health, metabolic markers, and cellular function.
Cardiovascular Risk and Major Heart Trials
The relationship between omega-3 fatty acids and heart health has been tested in several large randomized controlled trials, with varying results based on dose and formulation.
A 2026 review in Cardiovascular Drugs and Therapy examined landmark clinical trials in cardiovascular disease prevention. The authors noted that low-dose mixed EPA and DHA formulations were generally neutral in modern trials. However, higher-dose or single-component preparations showed distinct outcomes:
- JELIS Trial: Participants taking 1.8 grams per day of purified EPA had fewer major coronary events compared to control (2.8% versus 3.5%, hazard ratio 0.81).
- REDUCE-IT Trial: Patients with elevated triglycerides taking 4 grams per day of icosapent ethyl (a purified EPA formulation) showed a reduction in major ischemic events compared to placebo (17.2% versus 22.0%, hazard ratio 0.75).
- STRENGTH Trial: Testing 4 grams per day of a combined EPA and DHA carboxylic acid formulation showed no significant reduction in major cardiovascular events (12.0% versus 12.2%, hazard ratio 0.99).
Differences in biological exposure, pharmacological properties, and placebo choices likely contributed to these contrasting findings. Scientific guidelines note that omega-3 preparations should not be considered interchangeable, and treatment decisions depend on individual health profiles, dose, and formulation. Talk to your doctor or pharmacist to discuss cardiovascular risk management and prescription options.
Impact on Triglycerides and Metabolic Markers
Meta-analyses of clinical trials have evaluated how omega-3 supplementation influences circulating blood lipids and metabolic markers.
A 2026 meta-analysis in Nutrition, Metabolism and Cardiovascular Diseases pooled results from 24 randomized trials (2,043 total subjects) and reported several significant shifts:
- Triglycerides: Decreased by an average of 16.95 mg/dL across 21 trials (1,491 participants).
- HDL Cholesterol: Increased by 1.55 mg/dL across 22 trials (1,914 participants).
- Adiponectin: Increased by 0.96 μg/mL across 3 trials (198 participants).
- HbA1c: Decreased by 0.17% across 3 trials (283 participants).
Subgroup analyses showed that low-density lipoprotein (LDL) cholesterol decreased by 10.98 mg/dL in women (4 trials, 236 subjects) and by 13.77 mg/dL in individuals with polycystic ovary syndrome (PCOS) (3 trials, 180 subjects). Total cholesterol in women also decreased by 15.58 mg/dL across 4 trials.
A 2025 meta-analysis in Nutrients focused on marine omega-3 supplementation in adults with metabolic syndrome across 21 trials (~1,950 subjects). The analysis found that higher doses (>2,000 mg/day) produced the largest triglyceride reductions: -56.78 mg/dL for long-term use (over 12 weeks) and -50.87 mg/dL for short-term use (up to 8 weeks). Medium doses (1,000 to 2,000 mg/day) achieved smaller reductions ranging from -24.93 mg/dL to -31.84 mg/dL.
Comparing Supplement Forms: Krill Oil Versus Fish Oil
Researchers have also examined whether different chemical forms of omega-3s alter their absorption into the bloodstream. In fish oil, EPA and DHA are bound primarily as triglycerides, whereas krill oil delivers them mainly as phospholipids.
A 2026 double-blind randomized controlled trial published in The American Journal of Clinical Nutrition evaluated 72 healthy adults (53 females, 19 males) taking 1.1 grams per day of omega-3s from either krill oil or fish oil for 12 weeks.
- Plasma Levels: Krill oil supplementation led to roughly 1.5-fold higher increases in plasma EPA and DHA concentration changes over baseline compared to fish oil.
- Sex Differences: Females demonstrated a 1.5-fold greater increase in plasma EPA levels at 12 weeks compared to males, regardless of supplement type.
- Genetics: APOE4 gene carriers experienced 3-fold increases in EPA and 1.6-fold increases in DHA compared to baseline, though these shifts did not differ significantly from non-carriers.
The study concluded that krill oil increased plasma omega-3 levels more efficiently than fish oil at equivalent daily doses.
Inpatient Comparison: Fish Oil Versus Olive Oil Emulsions
Omega-3 formulations have also been studied in specialized medical settings. A 2026 systematic review in the Journal of Human Nutrition and Dietetics evaluated six studies comparing fish oil-based lipid emulsions to olive oil-based emulsions in intravenous parenteral nutrition.
The review found limited significant differences between the two formulations. The authors concluded that current evidence does not establish either fish oil or olive oil emulsions as superior to the other regarding immune function, systemic inflammation, or clinical outcomes in hospitalized patients.
Cellular Mechanisms: How EPA and DHA Function
Mechanistic research illustrates how EPA and DHA interact with cellular structures:
- EPA Functions: According to a 2026 review in the Journal of the Science of Food and Agriculture, EPA helps reduce reactive oxygen species, lowers oxidative stress, supports cell membrane stability, and aids endothelial health.
- DHA Functions: The same review notes that DHA modulates mitochondrial activity, promotes mitochondrial biogenesis, and facilitates fatty acid oxidation for cellular energy management.
- Inflammatory Signaling: A 2026 trial in cattle published in Journal of Animal Science found that encapsulated fish oil increased plasma pro-resolving oxylipins derived from omega-3s while temporarily decreasing pro-inflammatory oxylipins derived from omega-6s over 168 days.
- Exercise Combinations: An active clinical trial protocol in Contemporary Clinical Trials is currently testing 4 grams per day of omega-3 fish oil combined with high-intensity interval training (HIIT) over 10 weeks to explore joint effects on systemic inflammation and gut microbiota composition in adults with elevated BMI.
Safety Considerations and Medical Advice
While omega-3 fatty acids offer measurable nutritional effects, higher doses require careful attention to safety. The 2026 review in Cardiovascular Drugs and Therapy emphasizes that elevated prescription doses carry potential risks, including an increased risk of atrial fibrillation and bleeding complications.
If you are considering omega-3 supplementation, managing a medical condition, taking medications like blood thinners, or preparing for surgery, talk to your doctor or pharmacist. A healthcare professional can help you evaluate personal health goals, review potential interactions, and select appropriate doses.
Compare the picks: Best supplements for Heart & Circulation